Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
Titel:
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
Auteur:
Proetel, Ulrike Pletsch, Nadine Lauseker, Michael Müller, Martin C. Hanfstein, Benjamin Krause, Stefan W. Kalmanti, Lida Schreiber, Annette Heim, Dominik Baerlocher, Gabriela M. Hofmann, Wolf-Karsten Lange, Elisabeth Einsele, Hermann Wernli, Martin Kremers, Stephan Schlag, Rudolf Müller, Lothar Hänel, Mathias Link, Hartmut Hertenstein, Bernd Pfirrmann, Markus Hochhaus, Andreas Hasford, Joerg Hehlmann, Rüdiger Saußele, Susanne